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Crossveinless-2In Xenopus, dorsal–ventral (D–V) patterning can self-regulate after embryo bisection. This is mediated by an
extracellular network of proteins secreted by the dorsal and ventral centers of the gastrula. Different proteins
of similar activity can be secreted at these two poles, but under opposite transcriptional control. Here we
show that Crescent, a dorsal protein, can compensate for the loss of Sizzled, a ventral protein. Crescent is a
secreted Frizzled-Related Protein (sFRP) known to regulate Wnt8 and Wnt11 activity. We now ﬁnd that
Crescent also regulates the BMP pathway. Crescent expression was increased by the BMP antagonist Chordin
and repressed by BMP4, while the opposite was true for Sizzled. Crescent knock-down increased the
expression of BMP target genes, and synergized with Sizzled morpholinos. Thus, Crescent loss-of-function is
compensated by increased expression of its ventral counterpart Sizzled. Crescent overexpression dorsalized
whole embryos but not ventral half-embryos, indicating that Crescent requires a dorsal component to exert its
anti-BMP activity. Crescent protein lost its dorsalizing activity in Chordin-depleted embryos. When co-
injected, Crescent and Chordin proteins greatly synergized in the dorsalization of Xenopus embryos. The
molecular mechanism of these phenotypes is explained by the ability of Crescent to inhibit Tolloid
metalloproteinases, which normally degrade Chordin. Enzyme kinetic studies showed that Crescent was a
competitive inhibitor of Tolloid activity, which bound to Tolloid/BMP1 with a KD of 11 nM. In sum, Crescent is
a new component of the D–V pathway, which functions as the dorsal counterpart of Sizzled, through the
regulation of chordinases of the Tolloid family.De Robertis).
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The early embryo has the capacity of self-regulating pattern. For
example, when an amphibian embryo is bisected in such a way that
both halves contain a part of the dorsal Spemann organizer, each half
can regenerate a complete embryo and give rise to identical twins.
Similarly, transplantation of dorsal organizer tissue into the ventral
side of the gastrula embryo can generate a second morphogenetic
ﬁeld, resulting in the formation of Siamese twins (Spemann, 1938; De
Robertis, 2006). In Xenopus and zebraﬁsh, this remarkable inductive
capacity is mediated by a network of interacting secreted proteins
that establishes a gradient of Bone Morphogenetic Protein (BMP)
signaling along the D–V axis (Little and Mullins, 2006; De Robertis,
2009). The Spemann organizer, where BMP signaling level is lowest,
secretes the BMP antagonists Chordin, Noggin and Follistatin along
with two BMPs, ADMP and BMP2. In the ventral center, genes such as
Crossveinless-2 (CV2), BMP4, BMP7 and Sizzled are expressed inregions of high BMP signaling. This reciprocal transcriptional control
at opposite poles helps explain self-regulation (De Robertis, 2009).
Chordin is a key D–V regulator secreted in large amounts by dorsal
organizer tissue (Lee et al., 2006). Chordin binds to BMPs in the
extracellular space and prevents them from binding to their cognate
receptors, thuspreventing signaling. Chordin/BMPcomplexes formed in
more dorsal regions of the embryo are transported to ventral regions,
where BMP ligands are released from inactive Chordin/BMP complexes
by the cleavage of Chordin at two speciﬁc sites by Tolloid proteinases
(Piccolo et al., 1997). This cleavage is facilitated by Ont-1, a scaffold
protein of the Olfactomedin family that brings together Tolloid and its
substrate Chordin (Inomata et al., 2008). Mathematical modeling
suggests that the dorsal to ventral ﬂux of Chordin/BMP provides
robustness to the system (Ben-Zvi et al., 2008; Plouhinec and De
Robertis, 2009). The Chordin/BMP/Tolloid/CV2 network is an evolu-
tionarily conserved biochemical pathway that regulates D–V patterning
in many invertebrates, including Drosophila, and vertebrates (Little and
Mullins, 2006; De Robertis, 2008; Umulis et al., 2009).
Extracellular regulation of growth factor signals is a common
theme in embryonic patterning (Zakin and De Robertis, 2010). In
addition to Chordin, many other growth factor inhibitors are
produced in the Xenopus gastrula, such as the BMP inhibitors Noggin
(Zimmerman et al., 1996), Follistatin (Hemmati-Brivanlou et al.,
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Dickkopf (Dkk, an LRP6 inhibitor) (Glinka et al., 1998) and the sFRPs
Frzb, sFRP2, Sizzled and Crescent (De Robertis and Kuroda, 2004).
Multivalent inhibitors, such as Cerberus, which antagonizes Nodal,
BMP andWnt, and Coco/Cerl2, which inhibits Nodal, Activin and BMP,
are also secreted (Belo et al., 2009; Schwickert et al., 2010). CV2 is
expressed ventrally, where it avidly binds Chordin and Chordin/BMP
complexes, serving as a sink for the continuous ﬂow of dorsally
secreted molecules towards the ventral center (Ambrosio et al., 2008;
Kelley et al., 2009).
sFRPs contain Frizzled Wnt-binding domains and antagonize Wnt
signaling by preventing their binding to Frizzled receptors (Leyns
et al., 1997; Shibata et al., 2005). Structural predictions suggest that
the Frizzled domains in sFRPs may recognize lipid modiﬁcations
present in Wnts (Willert et al., 2003; Bazan and de Sauvage, 2009).
Some sFRPs have also been shown to enhance Wnt signaling (Uren
et al., 2000;Bovolenta et al., 2008). Importantly, Crescent and Frzbwere
recently found to greatly enhance the diffusion of Wnt in Xenopus
embryos, transporting Wnts and allowing them to signal at consid-
erable distances from where they are secreted (Mii and Taira, 2009).
Perhaps the most surprising function of any sFRP is that of the
ventrally expressed sFRP Sizzled (Salic et al., 1997), also called Ogon/
Mercedes in zebraﬁsh (Hammerschmidt et al., 1996). Sizzled appears
to have lost theWnt inhibitory activity of its Frizzled domain (Collavin
and Kirschner, 2003; Yabe et al., 2003). Importantly, Sizzled acts as a
feedback inhibitor of BMP signaling by binding to and competitively
inhibiting Tolloids, the metalloproteinases that cleave Chordin (Lee
et al., 2006; Muraoka et al., 2006). Sizzled is a key player in D–V self-
regulation: when BMP levels increase, sizzled expression in the ventral
center increases, causing inhibition of Tolloid enzymes, preventing
the release of BMP from Chordin/BMP complexes and, in this indirect
way, decreasing BMP signaling (Lee et al., 2006).
Crescent is the closest relative of Sizzled, and was initially isolated
in our laboratory as a cDNA expressed in the anterior endomeso-
dermal crescent of the chick embryo (Pfeffer et al., 1997). In Xenopus,
Crescent is expressed on the dorsal side of the gastrula in the deep
anterior endoderm and later in the prechordal plate (Pera and De
Robertis, 2000; Shibata et al., 2000). Crescent differs from Sizzled in
that it is able to bind and inhibit Wnt8 and Wnt11 activity in Xenopus
embryos (Shibata et al., 2005; Marvin et al., 2001; Schneider and
Mercola, 2001; Dickinson and Sive, 2009).
An interesting feature of theD–Vpatterning pathway is thatmany of
its components have counterparts of similar structure and biochemical
activity in thedorsal and in the ventral center. For example, Chordin and
CV2, as well as ADMP/BMP2 and BMP4/BMP7, are expressed on
opposite sides of the gastrula embryo (Fig. 1A). Given the sequence
similarity between Crescent and Sizzled, it seemed possible that these
two sFRPs could constitute an additional pair of secretedmoleculeswith
similar functions, expressed at different poles of the embryo under
opposite transcriptional control. If so, Crescent and Sizzled could
provide a new layer of resilience to the D–V patterning pathway.
In this paper we show that Crescent inhibits the activity of Tolloid
proteinases and is under the opposite transcriptional regulation from
that of Sizzled. Crescent bound to the Tolloid enzyme BMP1 with
afﬁnities within the physiological range. Enzyme kinetic analyses
showed that Crescent inhibited the cleavage of a ﬂuorogenic peptide
substratemimicking the Chordin cleavage site. Since Crescent itself was
not cleaved, it acts as a competitive inhibitor of Tolloid proteinases. This
novel function of Crescent in the Chordin/BMP pathway was supported
by embryological experiments in which the anti-BMP phenotypes
caused by Crescent overexpression were shown to require Chordin. Co-
injections of Crescent and Chordin protein into the blastula cavity had
synergistic dorsalizingeffects. Apointmutationmimicking the zebraﬁsh
ogon mutation eliminated Tolloid inhibition in biochemical assays and
greatly reduced the anti-BMP effects of Crescent protein in Xenopus
embryos. We propose that Crescent is a competitive inhibitor of Tolloidproteinases, and a novel component of the extracellular Chordin/BMP
biochemical pathway that regulates D–V patterning.
Materials and methods
Morpholino oligos and embryonic manipulations
Antisense Morpholinos (Gene Tools) were as described: Chordin
MO (Oelgeschläger et al., 2003), Sizzled MO (Collavin and Kirschner,
2003), and Crescent MO (5′-CTCTGACACACCTGAGGGCCATT-3′). Each
MO was microinjected four times radially into 4-cell embryos (34 ng
total). Bisection experiments were performed by cutting stage 9
embryos across their prospective D–V axis into two equal halves,
using a surgical blade. Embryos were bisected and cultured in 0.3 x
Modiﬁed Barth solution (Gurdon, 1976; Reversade and De Robertis,
2005). FormRNAmicroinjection, 200 pg of Xenopus crescent (Pera and
De Robertis, 2000) or crescentWobble were injected four times radially
into 2- or 4-cell embryos. CrescentWobble (…5′ ATG GCT CCA CAA CTG
TGC CAA 3′…) was generated by introducing 5 synonymous
mutations (underlined nucleotides) in the wild type Xenopus laevis
Crescent sequence targeted by our Crescent Morpholino. Double axes
were induced by microinjections of 2.5 or 5 pg of Wnt8 mRNA and
inhibited with 200 pg of Crescent or CrescentD103N mRNA. For protein
microinjections, afﬁnity-puriﬁed Crescent-Flag or CrescentD103N-Flag
(both at 5 μM, 60 nl), and recombinant mouse Chordin (2.5 μM, 60 nl)
or human BMP4 (0.4 μM, 60 nl, R&D Systems) weremicroinjected into
the blastocoele at mid-blastula (stage 8.5). Detailed procedures for
whole-mount in situ hybridization are available at http://www.hhmi.
ucla.edu/derobertis/protocol_page/protocol.html.
Biochemical methods
Xenopus Chordin-Myc was produced in baculovirus (Piccolo et al.,
1996) and subsequently afﬁnity-puriﬁed or used directly as substrate.
Xenopus Crescent-HA and Crescent-Flag were tagged at the C-terminus
by PCR. To generate CrescentD103N, the site-directed mutagenesis
Quikchange kit (Stratagene) was used. These proteins, plus Xlr-PC and
Szl-Fc (Lee et al., 2006), were produced by transient transfection
(Fugene, Roche) of HEK 293 T cells. Conditioned medium containing
secreted proteins was afﬁnity-puriﬁed using PC (Roche), Protein A
(Sigma), Flag (Sigma), or HA beads (Covance) according to manufac-
turer instructions. For BMP1enzymatic assays, commercial recombinant
human BMP1 protein (R&D Systems) and a ﬂuorogenic substrate
synthesized based on the sequence of the main cleavage site of Tolloid
on Chordin, Mca-SMQSDGAK-Dnp (Bachem), were used (Lee et al.,
2009). Reactions were performed with 25 μM ﬂuorogenic Chordin-
peptide substrate in Xld Buffer (Piccolo et al., 1997) with the addition of
0.01% Brij 35.
Enzymatic activities were measured in a ﬂuorescent plate reader
(excitation=320 nm, emission=405 nm) and initial velocities cal-
culated from the rate of ﬂuorescence increase in 60 minute reactions.
For enzyme kinetics studies, Lineweaver-Burk plots were constructed
using initial velocities (vi) obtained from ﬂuorometric enzyme assays
at different Chd-peptide and Crescent-Flag concentrations. Dixon
plots were generated by modifying the concentration of inhibitor for
two different substrate concentrations, and plotting the inverse of the
initial velocity versus the concentration of inhibitor. The kinetic
constants Km (Michaelis constant), Vmax (maximal velocity) and Ki
(inhibition constant) were calculated as described in Dixon andWebb
(1979). For Xlr and BMP1 in vitro enzymatic digestion assays, 30 nM
baculovirus Chd-Myc was incubated in Xld Buffer with afﬁnity-
puriﬁed Xlr-Flag or human BMP1 (R&D Systems) containing the
indicated concentrations of Szl-Fc, Crescent-Flag or Crescent-HA at
25 °C (or 37° in a few instances) for 2 hr. Western blots were
visualized using pico chemiluminescent substrate (Pierce) or the
LiCOR Odyssey infrared imager system.
Fig. 1. Xenopus crescent is expressed dorsally and repressed by BMP signaling. (A) D–V Patterning is regulated by proteins secreted by the dorsal and ventral signaling centers. For the
proteins listed, proteins of similar function are secreted by the two sides, but under opposite transcriptional control. (B) sFRPs of Xenopus (x), human (h), zebraﬁsh (z) and chicken
(ch) origin were compared using Molecular Evolutionary Genetics Analysis (MEGA) software (Tamura et al., 2007). Crescent and Sizzled are philogenetically related, and distant
from the other sFRPs. (C–E) Crescent expression is under negative transcriptional control by BMP4 signaling. Microinjection of Chordin (Chd) protein increases crescent transcripts,
while microinjection of BMP4 protein decreases crescent expression in stage 12 gastrulae. (F-H) sizzled expression is inhibited by injection of crescentmRNA andmarkedly expanded
upon depletion of Crescent (Cres MO); an uninjected sibling at stage 11 is shown for comparison.
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Surface plasmon resonance measurements were performed in a
BIAcore 3000 system. Afﬁnity puriﬁed Crescent-Flag protein, diluted
to 20 μg/ml in 10 mM sodium acetate (pH 5.0), was bound on acarboxymethylated dextran (CM5) sensor chip using amine coupling
to a level of approximately 6000 response units. Binding of
recombinant human BMP1 protein (carrier free, R&D Systems) and
washes were performed in Xld Buffer. Each experimental cycle
consisted of a ﬂow Crescent-Flag at various concentrations. After
320 D. Ploper et al. / Developmental Biology 352 (2011) 317–328each cycle, non-crosslinked proteins were removed by a ﬂow of
10 mM HCl in order to regenerate the chip surface. Data were
analyzed with BIAevaluation 4.1 software and curve-ﬁtting was done
with the assumption of one-to-one binding (Wang et al., 2003).
Quantitative RT-PCR
Total RNA from 10 whole embryos (at stage 11) per sample was
extracted with the Absolutely RNA Microprep kit (Stratagene).
Synthesis of cDNA was done using random hexamer primers and
the StrataScript Reverse Transcriptase (Stratagene). Quantitative RT–
PCRwas performed on theMx3000P (Stratagene) apparatus using the
Brilliant SYBR Green QPCR Master Mix (Stratagene). Measurements
were performed in quadruplicates and normalized to the expression
levels of ODC (Ornithine decarboxylase). The formula 2-ΔΔCt was used
to calculate fold induction values. Bars indicate standard deviations.
RT-PCR conditions and primers can be found at http://www.hhmi.
ucla.edu/derobertis/protocol_page/protocol.html.
Results
Crescent regulates BMP signaling
The Xenopus gastrula contains a dorsal and a ventral signaling
center under opposite transcriptional regulation by BMP signaling
(Fig. 1A). From a molecular standpoint, Crescent resembles Sizzled,
Chordin is like CV2, and ADMP/BMP2 and BMP4/BMP7 are all BMPs.
Within the sFRP family, Crescent is most similar to Sizzled (Fig. 1B).
This prompted us to investigate whether Crescent had a similar
biochemical activity to that of Sizzled (Lee et al., 2006).
To determine whether the expression of Crescent on the dorsal
region of the embryo was transcriptionally repressed by BMP signals,
we microinjected BMP4 or Chordin proteins into the blastocoele of
stage 8.5 Xenopus blastulae (Figs. 1C–E). Embryos injected with the
BMP antagonist Chordin showed increased levels of crescent tran-
scripts (n=9/9) (Fig. 1C), while embryos injected with BMP4 showed
decreased transcripts (n=11/14) (Fig. 1E) when compared to
uninjected controls (n=9/10) (Fig. 1D) at late gastrula. This indicated
that Crescent is normally repressed by BMPs, explaining its prefer-
ential expression on the dorsal side of the embryo, where BMP
signaling is low.
To study the function of Crescent during gastrulation, an antisense
morpholino (Cres MO) was designed. Crescent mRNA or Crescent MO
were injected into each blastomere of 4-cell stage Xenopus embryos.
Sizzled expression was used as the readout for regions of high BMP
signaling, since its transcription is activated by BMPs (Collavin and
Kirschner, 2003). Embryos overexpressing Crescent showed reduced
sizzled expression in the ventral side (n=14/16) (Fig. 1F), while
depletion of Crescent with MO expanded the ventral sizzled
expression (n=9/10) (Fig. 1H) compared to uninjected controls
(n=10/10) (Fig. 1G). Moreover, Crescent overexpression increased
Chordin transcripts (Figs. 2A and B), which are normally repressed by
BMP signaling (n=27/30). These results indicated that Crescent
regulates the BMP signaling gradient and came as a surprise, since
Crescent had previously only been implicated in inhibition of Wnt
signals (Pera and De Robertis, 2000; Shibata et al., 2005).
To assess the speciﬁcity of the Crescent MO, we designed a mutant
crescent mRNA, crescentWobble, which contains several mismatches
with the antisense morpholino but retains the identical amino acid
coding sequence (Fig. 2C). Depletion of Crescent (Cres MO) greatly
increased sizzled transcripts (Fig. 2E), while overexpression of
crescentWobble mRNA reduced them (Fig. 2F) compared to control
embryos (Fig. 2D). Co-injection of Cres MO and crescentWobble mRNA
rescued the Crescent MO phenotype (compare Figs. 2D–G), indicating
that the phenotype of Cres MO was speciﬁc. To further evaluate the
ventralizing phenotype displayed upon knockdown of Crescent, totalmRNA was collected from embryos injected with Cres MO and
uninjected controls, and quantitative RT-PCR were performed.
Knockdown of Crescent (Cres MO) led to an increase in the BMP
induced genes Xolloid related (Xlr) (2 H) (Dale et al., 2002), BMP4 (2I),
and Vent-1 (2 J), and to a decrease in the BMP repressed gene Chordin
(2 K) (Reversade and De Robertis, 2005).
The results presented so far indicate that Crescent normally
reduces BMP signaling. Our hypothesis is that Crescent and Sizzled
might control Tolloid activity from opposite poles of the embryo.
When Crescent is depleted, increased expression of Sizzled may
compensate in part for the lack of Crescent. If this were the case,
simultaneous depletion of both Crescent and Sizzled should better
relieve Tolloid proteinases from inhibition and cause increased
ventralization of the gastrula. Chordin expression was used to probe
for BMP signaling levels, since Chordin is transcriptionally inhibited by
BMP signals (Reversade and De Robertis, 2005). Embryos depleted of
either Crescent (n=24/28) or Sizzled (32/35) showed reduced
chordin transcripts (Figs. 2I–K). Indeed, embryos doubly depleted of
Crescent and Sizzled showed even more severely reduced chordin
levels (n=29/31) (Fig. 2L). We propose that Crescent and Sizzled
cooperate in vivo, from opposite poles of the embryo, to ﬁne tune the
D–V BMP signaling gradient during development (2P).
Crescent inhibits the degradation of chordin by Tolloid metalloproteinases
We next asked whether the mechanism by which Crescent
reduced BMP signaling was through inhibition of the Tolloid
proteinases that cleave the BMP antagonist Chordin (Fig. 2M). To
test this hypothesis, we conducted biochemical studies measuring the
digestion of Chordin by Tolloid in the presence of Crescent (Figs. 3A
and B). The reactions were performed using afﬁnity-puriﬁed Crescent
protein (Cres-Flag or Cres-HA) as the inhibitor, Xenopus Chordin
(Chd-myc) produced in baculovirus as the substrate, and either
commercial hBMP1 or afﬁnity-puriﬁed Xolloid-related-Flag (Xlr) as
the proteinase. The digestion reactions were performed as described
in Piccolo et al. (1997), and analyzed by Western blots using
antibodies against the Chd-Myc tag.
Chd-myc was digested by puriﬁed Xlr protein (Fig. 3A, compare
lanes 1 and 2). Addition of Crescent protein inhibited the proteolytic
cleavage of Chordin by Xlr (compare lanes 2 and 3); the level of
inhibitionwas comparable to that achieved by the same concentration
of Sizzled (Fig. 3A, lane 4), a bona ﬁde Tolloid inhibitor (Lee et al.,
2006). This result could also be reproduced using another Tolloid
proteinase, hBMP1 (data not shown). Furthermore, the inhibitory
effect of Crescent on Tolloid enzymes was dose-dependent (Fig. 3B).
One possible explanation for the inhibition of Tolloid activity could
be that Crescent itself might be a substrate for Tolloid proteinases.
This possibility could be ruled out, for Crescent-Flag protein was not
digested by BMP1 (Fig. 3C, lanes 1 and 2), while Chordin was
degraded in the same experiment (Fig. 3C, lanes 3 and 4). The purity
of our Crescent-ﬂag proteins was veriﬁed through Coomassie Brilliant
Blue staining (Fig. 3D). These results show that Crescent protein is an
inhibitor of Tolloid proteinases.
Crescent binds and competitively inhibits Tolloid proteinases
To analyze the mechanism by which Crescent inhibits Tolloids, a
Chordin-mimicking ﬂuorogenic substrate was used (Chd-peptide).
This ﬂuorogenic substrate is an octapeptide containing target amino
acids of Chordin recognized by Tolloid metalloproteinases. The
octapeptide is ﬂanked by a ﬂuorophore on one side and its quencher
on the other (Lee et al., 2009). Upon cleavage by Tolloids, the
ﬂuorophore is released from quenching and emits ﬂuorescence at
405 nm. When the kinetics of the enzyme reaction was analyzed at
increasing concentrations of the substrate (ﬂuorogenic Chd-peptide),
double reciprocal Lineweaver-Burk plots (Fig. 4A) showed that
Fig. 2. Crescent regulates BMP signaling. (A,B) Microinjection of crescentmRNA expands the expression of chordin, a gene that is negatively regulated by BMP signaling. (C) Diagram
showing a control crescentmRNA containing wobble position mutations is no longer targeted by Crescent MO. (D–G) Crescent MO greatly expands expression of the ventral (high-
BMP) marker sizzled, while crescentWobble mRNA reduces Sizzled expression and rescues the effects of Crescent MO. (H–K) Knockdown of Crescent increases the transcript levels of
BMP induced genes (Xlr, BMP4, Vent-1), while reducing the levels of chordin, a gene repressed by BMP signaling. (L–O) chordinmRNA expression is reduced by Crescent MO or Sizzled
MO. Note that simultaneous depletion of both sFRPs causes a synergistic ventralizing effect, greatly reducing chordin transcripts at early gastrula. (P) Model in which the BMP
gradient is represented by a see-saw in which dorsal and ventral inhibitors of Tolloid metalloproteinases adjust the D–V gradient through the proteolytic degradation of Chordin.
Blue arrows symbolize transcriptional regulation by BMPs, black arrows indicate direct protein–protein interactions.
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Webb, 1979): at two concentrations of Crescent-Flag, the apparent
Km for the substrate changed, while the maximal velocity (Vmax) did
not.
The inhibition constant (Ki) is deﬁned as the concentration of
inhibitor at which half of the enzyme is in complex with the inhibitor.
The Ki for Crescent inhibition was obtained using a Dixon Plot
(Fig. 4B), a graphical method which yields the Ki directly without
calculation. The initial velocities (vi) were determined at a series of
inhibitor concentrations, and then plotted as 1/vi against the
concentration of inhibitor [I]. These reactions were performed at
two substrate concentrations, producing two slopes. The point at
which both these lines intersect is equal to −Ki in the case of acompetitive inhibitor (Dixon and Webb, 1979). The Ki of Crescent
determined by this method was 59 nM (Fig. 4B).
After determining that Crescent is a competitive inhibitor of
Tolloids, we analyzed the physical properties of their interaction. The
binding afﬁnity between Crescent and Tolloid was measured by
surface plasmon resonance (BIAcore) analyses (Fig. 4C). Crescent-Flag
proteins were covalently crosslinked to the surface of a sensor chip.
hBMP1 was passed over this chip at constant ﬂow, and changes in the
refractive index caused by associations and dissociations recorded for
different concentrations of hBMP1 (Fig. 4C). The afﬁnity of the
binding, expressed by the dissociation constant (KD), was calculated
from the quotient between the kinetic rates of association and
dissociation. The KD for the interaction between Crescent and BMP1
Fig. 3. Crescent inhibits the proteolytic activity of Xlr or BMP1 on Chordin. (A) Puriﬁed Crescent-HA (150 nM) inhibited the proteolysis of Chordin-myc by Xlr to the same extent as
Sizzled-Fc at the same concentration. (B) Crescent-HA inhibited in a dose-dependent manner (16, 50, 150 nM) the cleavage of Chordin (30 nM) by BMP1 (10 nM). (C) Crescent-Flag
(150 nM)was not cleaved by BMP1 (10 nM) (compare lane 1 and 2), while Chordin-myc (30 nM)was cleaved in the same experiment (lanes 3 and 4). (D) Crescent proteins afﬁnity-
puriﬁed over an anti-ﬂag matrix stained with Coomassie Brilliant Blue to indicate their purity.
322 D. Ploper et al. / Developmental Biology 352 (2011) 317–328was on average 11 nM, which corresponds to a binding of high afﬁnity
within the physiological range (Hojima et al., 1985).
We conclude from these biochemical studies that Crescent
competes for the binding of Chordin substrates to the BMP1/Tolloid
catalytic site, and that this binding has a dissociation constant in the
10−9 Molar range.
Chordin is required for the dorsalizing activity of crescent
In previous work, the clue that led to the discovery of the
mechanism of action of Sizzled was the observation that microinjec-
tions of sizzled mRNA had no effect on ventral half-embryos bisected
at blastula. This indicated that Sizzled required a dorsal component in
order to mediate its dorsalizing (anti-BMP) effects (Lee et al., 2006). A
similar approach was taken here for Crescent. Microinjections of
Crescent mRNA dorsalized whole Xenopus embryos, as indicated by
the expansion of the pan-neural marker SOX2 (Figs. 5A and B). To
determine whether dorsal components were required for this anti-
BMP activity, bisection experiments were carried out (Reversade and
De Robertis, 2005). Only the dorsal halves of Crescent-injected
embryos showed an expansion of SOX2 (n=16/16), while ventral
halves were unaffected by Crescent overexpression (Fig. 5B). Control
experiments with chordinmRNA showed that this BMP inhibitor very
effectively dorsalized ventral half-embryos (Oelgeschläger et al., 2003
and data not shown). These results show that Crescent is incapable of
affecting ventral tissues directly, and requires dorsal components in
order to elicit its effects.
Our biochemical experiments indicated that Chordinwas the likely
dorsal component required for the dorsalizing activity of Crescent. To
test this hypothesis, we injected Crescent protein into blastula
embryos that had been previously depleted of Chordin by antisense
Chd morpholino oligos (Oelgeschläger et al., 2003). As expected,
Chordin-depleted embryos showed classical ventralized features
(n=15/16), with reduction of Rx2a and an increase of posterior
Sizzled (Szl), which marks ventral BMP4/7 signaling (Figs. 5C and D).Crescent protein injected into the blastocoele caused dorsalization
with an expansion of the forebrain and eye marker Rx2a (n=36/39)
(Fig. 5E, compare to C). (The anterior and ventral expression of Sizzled
also observed in 5E is due to the upregulation of BMP2, in dorsalized
embryos; BMP2 is expressed in this region when BMP signaling is
lowered, Inomata et al., 2008). However, in embryos that had been
previously depleted of Chordin, Crescent protein was devoid of
dorsalizing (anti-BMP) activity, as indicated by the reduction of Rx2a
and residual posterior Szl expression (n=29/34) (Fig. 5F). These
results indicate that Crescent requires Chordin in order to dorsalize
the Xenopus embryo.
A crescent mutant mimicking an ogon mutation has impaired
anti-BMP activity
The isolation of the ogon/mercedes mutation in zebraﬁsh opened
the way to the discovery of the role of Sizzled in BMP signaling. This
point mutation is located in the cysteine-rich frizzled domain.
SizzledOGON, in which an Aspartic acid is replaced by an Asparagine,
renders Ogon/Sizzled biologically inactive (Yabe et al., 2003).
Introducing this mutation into Xenopus sizzled (sizzledOGON) causes it
to lose its ability to inhibit Tolloid Proteinases (Lee et al., 2006). Taking
advantage of the sequence conservation between Crescent and
Sizzled, we made a construct mimicking the ogon mutation in
Crescent, CrescentD103N (Fig. 6A). When microinjected into the
blastocele of Xenopus embryos, afﬁnity-puriﬁed CrescentD103N protein
(n=18/21) was unable to expand the dorsal marker Rx2a when
compared to the same amount of microinjected CrescentWT protein
(18/18) (Figs. 6B–D). In biochemical experiments, CrescentWT
inhibited cleavage of the ﬂuorogenic Chd-peptide by BMP1 enzyme
in a dose-dependent manner (Fig. 6E), while the point mutant
CrescentD103N failed to inhibit the reaction at the same concentrations
(Fig. 6F). Moreover, embryos injected with CrescentD103N were less
dorsalized than those injected with CrescentWT protein (Supplemen-
tal Fig. S1). The CrescentD103N mutant loses Tolloid-inhibiting activity,
Fig. 4. Crescent binds and competitively inhibits Tolloid Proteinases. (A) Lineweaver-
Burk plot (1/vi over 1/[S]) showing that Crescent is a competitive inhibitor of Tolloid
proteinases. (B) Dixon Plot (1/vi over [I]) from which the Ki (59 nM) could be obtained
directly. (C) BIAcore surface Plasmon resonance sensograms for the Crescent-BMP1
interaction in real time, showing an average KD of 11 nM. The points in timewhen BMP1
binding starts, and when washing with buffer starts, are indicated.
Fig. 5. Crescent requires Chordin in order to dorsalize the embryo. (A) Embryos bisected
along their D–V axis. The dorsal half self-regulates, forming a well-proportioned
embryo, while the ventral half forms a belly piece consisting of ventral tissues.
(B) Crescent mRNA microinjection increases SOX2 expression in dorsal halves, but has
no effect on ventral half-embryos. Thus, the dorsalizing activity of Crescent requires a
dorsal component. (C) Uninjected control embryos showing normal Rx2a and Sizzled
transcript levels at stage 20. (D) Embryos injected with Chordin MO showing a
ventralized phenotype consisting of reduced Rx2a and expanded posterior Sizzled
transcripts (inset). (E) Injection of Crescent protein into the blastocoele dorsalizes
embryos, expanding Rx2a expression, decreasing Sizzled expression in the posterior-
ventral region and increasing Sizzled in the anterior-ventral region (where BMP2 is
expressed). (F) Injections of Crescent protein into Chordin-depleted embryos are
without dorsalizing effects; this result indicates that Crescent protein requires Chordin
to dorsalize Xenopus embryos. Insets show lateral views.
323D. Ploper et al. / Developmental Biology 352 (2011) 317–328but retains its ability to inhibit Wnt signaling. This was ascertained by
coinjecting Wnt8 mRNA together with crescentWT or crescentD103N
mRNA (Figs. 6G–I). Axis induction by xWnt8 mRNA (n=39/47, 83%
with secondary axes) was blocked both by crescentWT (n=55/55) or
crescentD103N (n=52/52). We note that at 5 pg of xWnt8 mRNA,
although secondary axes were eliminated, some dorsalizing activity
persisted (although at 2.5 pg all effects of xWnt8 were eliminated), as
shown in Fig. 6I. This indicates that a small amount of anti-Wnt
potency might be affected in the mutant. We conclude that the two
functions of Crescent are separable, with CrescentD103N losing itsTolloid-inhibiting activity but retaining its function as aWnt inhibitor.
The dorsalizing phenotypic activity of Crescent can bemostly ascribed
to its effects on BMP signaling through Tolloid inhibition.
We next tested the effect of Crescent and its Ogon-like mutant in
embryos sensitized by microinjection of a low amount of Chordin
protein that doesnot changeD–Vpatterningon its own(Fig. 6J, compare
Fig. 6. A Crescent mutant mimicking the Ogon mutation lacks Tolloid inhibitory activity and has less anti-BMP activity in the Xenopus embryo. (A) Flag-tagged afﬁnity-puriﬁed
protein CrescentWT and CrescentD103N. (B–D) Microinjection of CrescentWT protein (2.5 μM) into the blastocele dorsalizes embryos and expands Rx2a expression, while
microinjection of the same concentration of CrescentD103N had reduced dorsalizing ability and was unable to expand Rx2a expression. (E, F) CrescentWT inhibited cleavage of a
ﬂuorogenic Chordin peptide by BMP1 enzyme in a dose-dependent manner, whereas CrescentD103N was unable to inhibit this reaction. (G–I) CrescentD103N is able to inhibit the
induction of secondary axes by xWnt8 mRNA, indicating that the Wnt-inhibiting and Tolloid-inhibiting activities of CrescentWT are separable. (J–L) A sub-threshold amount of
Chordin protein injected into the blastocoele has very limited effect. If, in addition to this amount of Chordin, embryos also received a modest amount of CrescentWT, synergetic
cooperation between Crescent and Chordin proteins was observed, manifested as an extreme increase in Rx2a expression in ectoderm. Embryos injected with CrescentD103N,
although retaining a dorsally “kinked” phenotype (probably caused by inhibition of convergence and extension movements that require Wnt signaling), did not exhibit this increase
in the Rx2a forebrain marker, when co-injected with Chordin protein. Insets show frontal views of embryos without injection of Chordin protein.
324 D. Ploper et al. / Developmental Biology 352 (2011) 317–328with its inset). CrescentWT protein was injected into the blastocoele in
amounts that only slightly increased dorsalization (n=8/8) (Fig. 6J,
inset). Interestingly, when Chordin and Crescent proteins were co-
injected, amassive expansion of the forebrainmarker Rx2awas induced
(n=9/12) (Fig. 6K). This strong synergy between Chordin and Crescenton Rx2a expression was not observed when the same amount of
CrescentD103N protein was co-injected (n=6/6) (compare Figs. 6K–L).
The equivalent point mutations in the frizzled domain of Crescent
(this work) or of Sizzled (Lee et al., 2006) caused both proteins to lose
their metalloproteinase inhibiting activity. The remarkable synergistic
325D. Ploper et al. / Developmental Biology 352 (2011) 317–328interactionbetweenmicroinjectedChordin andCrescent is explainedby
the inhibition of endogenous Tolloid enzymes, which normally degrade
Chordin, by Crescent protein.
Discussion
Crescent is a Tolloid inhibitor
An intriguing question is why certain putative Wnt antagonists
bearing frizzled domains, such as Crescent or Sizzled, and BMP
antagonists such as Chordin or Noggin, cause very similar over-
expression phenotypes. For example, in zebraﬁsh overexpression of
Sizzled or Chordin causes embryos to become dorso-anteriorized and
lose ventral BMP-dependent structures such as the ventral ﬁn (Yabe
et al., 2003). This puzzle started to be answered when the surprising
molecularmechanism of Sizzled actionwas discovered. Sizzled plays a
critical role in the BMP pathway as a competitive inhibitor of the
Tolloid proteinases that degrade the BMP antagonist Chordin, rather
than through the modulation of Wnt signaling (Lee et al., 2006;
Muraoka et al., 2006).
This unexpected function of Sizzled in Chordin proteolysis led us to
test here whether the sFRP Crescent, expressed in the opposite pole of
the developing gastrula, might have a similar function. A few hints
pointed in this direction: within the sFRP family, Crescent is closest to
Sizzled in terms of primary structure (44% identity, 63% similarity)
(Collavin and Kirschner, 2003), and is expressed at the time and place
in the developing gastrula at which Tolloid inhibition is likely to be
important (Pera and De Robertis, 2000; Shibata et al., 2000). Crescent
has well-documented effects on Wnt8 and Wnt11 activity in Xenopus
embryos (Shibata et al., 2005; Mii and Taira, 2009; Dickinson and Sive,
2009). By regulating the cleavage of Chordin by Tolloids, Crescent is
now shown to be able to regulate both the BMP andWnt pathways in
the developing embryo.
Crescent inhibits Tolloid proteinases, which are known to provide
the rate-limiting step in the Chordin/BMP pathway (Lee et al., 2009).
Using biochemical and embryological approaches, we found that
Crescent is a competitive inhibitor of Tolloids, which enhance BMP
signaling by inhibiting the cleavage of the BMP antagonist Chordin in
the extracellular space. Crescent protein inhibited the proteolytic
cleavage of Chordin by Xlr or BMP1 in vitro, without itself being
cleaved by the proteases. Crescent functions as a competitive inhibitor
of Tolloid metalloproteinases. We also found that Crescent protein
was able to bind BMP1 with high afﬁnity, in the physiologically
relevant nanomolar range (Hojima et al., 1985; Lee et al., 2006).
Tolloid inhibition explains the dorsalized phenotypes caused by
Crescent protein microinjections. Crescent was unable to dorsalize
ventral half-embryos and required endogenous Chordin to dorsalize
intact Xenopus embryos. CrescentD103N is a point mutant mimicking
the Ogon mutation in Sizzled, which loses its Tolloid inhibiting
activity in vitro while retaining its Wnt-inhibiting properties.
Interestingly, this mutant displayed a much reduced dorsalizing
capacity and was ineffective in cooperating with Chordin protein
when coinjected into Xenopus embryos (Fig. 6). Thus, the Tolloid
inhibiting activity of Crescent appears to be responsible for a
signiﬁcant part of its phenotypic effects in Xenopus embryos.
Crescent is at the intersection of Wnt and BMP signaling
Xenopus Crescent was isolated in a screen for proteins secreted in
gastrulating Xenopus embryos and was found to be expressed in
Spemann's organizer, in particular at the leading edge of the
endomesoderm (Pera and De Robertis, 2000). Like all sFRPs, Crescent
contains a cysteine-rich domain (CRD) homologous to the extracel-
lular domain present in Frizzled receptors (Pera and De Robertis,
2000; Shibata et al., 2000). This is whymost sFRPs, with the exception
of Sizzled, are thought to bindWnt ligands and regulateWnt signaling(Leyns et al., 1997; De Robertis and Kuroda, 2004; Bovolenta et al.,
2008).
Crescent binds to with Wnt11 and Wnt5a and has a role in the
regulation of convergent extension movements during gastrulation
and neurulation, via modulation of the non-canonical Wnt pathway
(Pera and De Robertis, 2000; Shibata et al., 2005). The role of Crescent
as a Wnt inhibitor is displayed during the development of the
stomodeum or mouth, in which Crescent and Frzb are required to
antagonize Wnt signaling; low levels of Wnt are essential for
perforation of the buccopharyngeal membrane (Dickinson and Sive,
2009). Wnt signaling inhibition by Crescent is also critical for heart
development (Marvin et al., 2001; Schneider and Mercola, 2001).
Recently, a new twist in the Wnt-regulating ability of Crescent has
been discovered. Experiments in Xenopus have demonstrated that
Crescent and Frzb enhance the diffusion of Wnts in the gastrulating
embryo (Mii and Taira, 2009). Crescent increased the diffusion of
Venus-taggedWnt8 andWnt11. Crescent is thought to achieve this by
binding and transporting Wnts, improving their diffusibility. Wnt
ligands transported by Crescent retain signaling capacity and Crescent
has a biphasic effect: at low concentrations the interaction between
Crescent and Wnt8 causes an increase in canonical Wnt signaling at a
distance, while at high concentrations Crescent acts as a Wnt
antagonist. It is conceivable that the increased diffusibility of Wnt
ligands when co-injected with Crescent might be related to the
inhibition of Tolloid metalloproteinases. Tolloid proteinases digest a
diverse set of precursors into mature functional proteins. Among
these substrates are many proteins important in the formation of the
extracellular matrix, such as ﬁbrillar procollagens (BMP1 is also
known as Procollagen C peptidase), Latent TGF-β-binding protein
(LTBP), Lysyl oxidase, Promyostatin, Osteoglycin and Biglycan
(Hopkins et al., 2007). Tolloids play fundamental roles in develop-
ment, and it is thought that many of these involve remodeling of the
extracellular matrix (Hopkins et al., 2007). Inhibition of Tolloids,
causing failure to properly process precursors of the extracellular
matrix, might modify the landscape through which morphogens need
to diffuse.
One important question that we were unable to address
experimentally is whether the binding of Wnt to Crescent modiﬁed
its ability to inhibit Tolloid protease activity. This experiment was
attempted, but failed because the detergent-containing buffer
required to maintain puriﬁed Wnt in solution, as well as conditioned
medium from cell cultures, are incompatible with the biochemical
assays of Tolloid activity. It is, however, an interesting question to
contemplate, for if Wnt binding to Crescent modulated its inhibition
of Tolloid, Crescent might behave as a receptor of a Wnt activity that
would function entirely in the extracellular space.
sFRP constitute the largest family of Wnt inhibitors, for which a
growing number of novel Wnt-independent functions are being
discovered (Bovolenta et al., 2008). Of these alternative Wnt-
independent roles for sFRPs, the best established one is that of Sizzled
as a competitive inhibitor of Tolloid Proteinases (Lee et al., 2006;
Muraoka et al., 2006). Sizzled does not antagonize Wnt signaling in
vivo (Collavin and Kirschner, 2003; Yabe et al., 2003), but instead acts
as a feedback inhibitor of BMP signaling by competitively inhibiting
the cleavage of the BMP antagonist Chordin (Lee et al., 2006; Muraoka
et al., 2006). In addition, sFRP2 has been recently shown to act as an
enhancer of the procollagen C proteinase activity (Kobayashi et al.,
2009). It seems likely that additional functions for sFRPs will continue
to be uncovered.
Crescent is part of the D–V patterning pathway
As shown in Fig. 7, patterning of the D–V axis is mediated by an
extracellular network of interacting proteins. At the heart of this
network is the signaling gradient generated by BMP-Chordin
antagonism (Fig. 7A). BMPs (BMP2/4/7 and ADMP) are secreted
Fig. 7.Model of the extracellular network of proteins that control D–V patterning. Crescent was shown here to be a component of the extracellular biochemical network that controls
D–V patterning. Arrows in blue represent transcriptional regulation by BMPs, arrows in black symbolize direct protein–protein interactions, and the red arrows indicate ﬂux of
Chordin/ADMP/BMP from the dorsal toward the ventral side of the embryo. Each protein–protein interaction indicated here is supported by biochemical and embryological studies
in Xenopus. (A) The BMP/Chordin gradient plays a central role in D–V patterning. (B) Tolloid metalloproteinases are inhibited by Crescent from the dorsal and Sizzled from the
ventral side. (C) The extracellular biochemical pathway of D–V development in Xenopus embryos, including the ﬂux of Chordin/BMP complexes from dorsal to ventral. Two
important regulators of the Chordin/BMP pathway have been omitted for simplicity in this diagram. One is Ont-1, an adaptor Olfactomedin-related protein that binds both Chordin
and Tolloid, which facilitates Chordin proteolysis (Inomata et al., 2008). The other regulator is Twisted-gastrulation (Tsg), a protein that binds both BMP and Chordin, facilitating
BMP signaling, the binding of BMP to Chordin, and the cleavage of Chordin by Tolloids (De Robertis and Kuroda, 2004; Little and Mullins, 2006).
326 D. Ploper et al. / Developmental Biology 352 (2011) 317–328both ventrally and dorsally, and their signaling causes cell differen-
tiation towards ventral fates. The dorsally secreted antagonist Chordin
binds BMPs and impedes the binding of BMPs to their receptors,
ensuring that the dorsal side of the embryo is kept free of BMP
signaling (Piccolo et al., 1996). The Chordin/BMP antagonism creates a
gradient of BMP signaling along the D–V axis, which is reinforced by
an array of proteins that help keep BMP signaling high on the ventral
and low in the dorsal side, either by sequestering, transporting or
solubilizing BMP ligands (Zakin and De Robertis, 2010).
Many components of this extracellular network that regulates D–V
patterning have counterparts of similar structure and function
secreted under opposite transcriptional control on the other side of
the embryo. Examples of this are BMP2 and ADMP on the dorsal and
BMP4 and BMP7 on the ventral side (Reversade and De Robertis,
2005; Inomata et al., 2008), as well as Chordin dorsally and the
structurally related protein CV2 on the ventral side (Ambrosio et al.,
2008). The experiments presented here indicate that Crescent and
Sizzled constitute a new pair of proteins expressed at opposite poles
of the embryo and having similar functions (Fig. 7B). Their opposing
transcriptional regulation should confer additional resilience and
robustness to the regulatory network. For example, in loss of function
experiments when Crescent expression is knocked down by morpho-
linos, the transcriptional upregulation of Sizzled is able to compensate
in part, explainingwhy the double knockdown of Crescent and Sizzled
causes a much severe high-BMP phenotype (Fig. 2).
BMP antagonism by Chordin is not irreversible. BMPs can be
liberated from this inhibition by Tolloid metalloproteinases that
cleave Chordin, enabling BMPs to signal again (Piccolo et al., 1997). In
the Xenopus embryo, 3 Tolloid enzymes are expressed: BMP1, Xolloid
(Xld) and Xolloid Related (Xlr). While the ﬁrst two are expressed
ubiquitously in the early embryo, Xlr is transcriptionally upregulated
in more ventral regions by BMP4/7 signaling (Goodman et al., 1998;
Dale et al., 2002). These metalloproteinases release BMPs from the
Chordin-BMP complex, allowing BMPs to signal (Fig. 7C). The
regulation of Tolloid activity is crucial to D–V patterning.
CV2 is a secretedmolecule that contains Chordin-like domains that
bind BMPs, but remains localized at its site of synthesis on the ventral
side (Rentzsch et al., 2006; Serpe et al., 2008; Ambrosio et al., 2008;Zakin et al., 2010). Acting as an anti-BMP, CV2 binds BMPs and
promotes their endocytosis and destruction, serving as a feedback
inhibitor (Zhang et al., 2008; Kelley et al., 2009). CV2 also acts as a
pro-BMP. Since it remains near the cells where it was produced, CV2
also functions as a molecular sink, concentrating Chordin/BMP
complexes diffusing from more dorsal regions on the ventral side
(Ambrosio et al., 2008; Blair, 2007). Once concentrated on the ventral
region, Chordin/BMP complexes can be cleaved by Tolloids (with the
help of the extracelluar Ont-1 scaffold protein, Inomata et al., 2008),
liberating active BMPs (Fig. 7C) which allows the embryo to reach
peak BMP signaling levels in the ventral center (reviewed in Zakin and
De Robertis (2010)).
Tolloidmetalloproteinases play a crucial role in the D–V patterning
pathway, and the ventral and dorsal signaling centers regulate their
proteolytic activity by secreting proteins that can inhibit these
enzymes. An additional inhibitory feedback loop is provided by the
recently discovered ability of BMP4 to inhibit Tolloids (Fig. 7C) when
its levels become high (Lee et al., 2009). Since Tolloid proteinases
constitute the rate-limiting step in the D–V Chordin/BMP pathway, it
is not surprising that these enzymes are highly regulated. Sizzled,
produced abundantly on the ventral side (Lee et al., 2006), serves as
an important negative feedback inhibitor. On the opposite side of the
gastrulating embryo, Crescent similarly protects Chordin from Tolloid
metalloproteinases by competitively inhibiting them, ensuring opti-
mal levels of Chordin on the dorsal side. Self-regulation of D–V pattern
results from this opposition between dorsal and ventral secreted BMP
signals and their extracellular regulators.
Crescent in evolution
From an evolutionary standpoint, the Chordin/BMP/Tolloid path-
way represents the ancestral D–V patterning system, which has been
conserved in the early embryos of Drosophila, beetles, spiders,
hemichordates, amphioxus, ﬁsh, amphibians and birds (reviewed in
De Robertis, 2008; Umulis et al., 2009). Drosophila has retained many
components of the system (Short-gastrulation/Chordin, Dpp/BMP,
Tolloid, Tsg and CV2), but its genome does not contain even a single
sFRP. Therefore, the D–V system of secreted proteins can generate
327D. Ploper et al. / Developmental Biology 352 (2011) 317–328pattern without Crescent or Sizzled. However, sFRPs are found in
some invertebrates such as nematodes and annelids, so insects must
have undergone gene loss. Like Xenopus, the chick embryo expresses
Crescent and Sizzled abundantly in dorsal and ventral regions,
respectively (Pfeffer et al., 1997; Wittler et al., 2008). It is therefore
very surprising that a functional Crescent is not present in the genome
of placental mammals. The platypus (Ornithorhynchus anatinus),
contains a perfect copy of Crescent (Warren et al., 2008). An intact
crescent gene is also found in the opossum (Monodelphis domestica), a
marsupial. However, in the genome of placental mammals Crescent
can no longer be identiﬁed, except in the dog genome (Canis lupus
familiaris) (Lindblad-Toh et al., 2005), in which a pseudogene
containing multiple inactivating mutations and deletions in Crescent
is still recognizable (J.L. Plouhinec and E.M.D.R., unpublished
observations). Perhaps the ﬁne regulation of D–V pattern was no
longer needed after the mammalian egg lost its yolk (which is still
present in the platypus) and consequently the need for self-regulation
of pattern during the epiboly movements by which the embryo
surrounds the yolk. In evolution, once a gene is no longer needed, it is
rapidly lost (De Robertis, 2008). Although no longer required for
patterning mice and men, Crescent is a conserved gene important in
the regulative development of lower vertebrates, which functions in
both the Wnt and the BMP signaling pathways.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.029.
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